Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

DDIT3, STT3A (ITM1), ARG2 and FAM129A (Niban, C1orf24) in diagnosing thyroid carcinoma: variables that may affect the performance of this antibody-based test and promise.

Carvalheira GM, Nozima BH, Riggins GJ, Cerutti JM.

Mod Pathol. 2013 Apr;26(4):611-3. doi: 10.1038/modpathol.2012.212. No abstract available.

2.

The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.

Sigstad E, Paus E, Bjøro T, Berner A, Grøholt KK, Jørgensen LH, Sobrinho-Simões M, Holm R, Warren DJ.

Mod Pathol. 2012 Apr;25(4):537-47. doi: 10.1038/modpathol.2011.188. Epub 2011 Dec 9.

3.

Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'.

Sigstad E, Paus E, Bjøro T, Berner A, Grøholt KK, Jørgensen LH, Sobrinho-Simões M, Holm R, Warren DJ.

Mod Pathol. 2013 Apr;26(4):613-5. doi: 10.1038/modpathol.2013.39. No abstract available.

4.

Diagnosis of suspicious thyroid nodules using four protein biomarkers.

Cerutti JM, Latini FR, Nakabashi C, Delcelo R, Andrade VP, Amadei MJ, Maciel RM, Hojaij FC, Hollis D, Shoemaker J, Riggins GJ.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3311-8.

5.

A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.

Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ.

J Clin Invest. 2004 Apr;113(8):1234-42.

6.

STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.

Patel MR, Stadler ME, Deal AM, Kim HS, Shores CG, Zanation AM.

Laryngoscope. 2011 May;121(5):983-9. doi: 10.1002/lary.21736.

PMID:
21520112
7.

[Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].

Cerutti JM.

Arq Bras Endocrinol Metabol. 2007 Jul;51(5):832-42. Review. Portuguese.

8.

Aspiration cytology of parathyroid adenoma: radioimmunoassay of parathormone in aspirate as a helpful diagnostic tool.

Ryşka A, Kerekes Z, Cáp J.

Acta Cytol. 1998 May-Jun;42(3):826-7. No abstract available.

PMID:
9622722
9.

A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis.

Matsumoto F, Fujii H, Abe M, Kajino K, Kobayashi T, Matsumoto T, Ikeda K, Hino O.

Hum Pathol. 2006 Dec;37(12):1592-600. Epub 2006 Sep 1.

PMID:
16949643
10.

Thyroid tumors.

Seesko HG, Wells SA Jr.

Immunol Ser. 1990;53:431-52. Review. No abstract available.

PMID:
2100571
11.

Arginase and ornithine, as markers in human non-small cell lung carcinoma.

Süer Gökmen S, Yörük Y, Cakir E, Yorulmaz F, Gülen S.

Cancer Biochem Biophys. 1999 Jul;17(1-2):125-31.

PMID:
10738908
12.

Differentiation of follicular adenoma and carcinoma of thyroid by immunohistochemical demonstration of ceruloplasmin.

Vaideeswar P, Pandit AA, Khilnani PH, Powar HS.

Indian J Pathol Microbiol. 1994 Apr;37(2):165-9.

PMID:
7959983
13.

Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.

Chang E, Park DI, Kim YJ, Kim BK, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim HD, Kim DH, Kim YH.

Hepatogastroenterology. 2010 Jul-Aug;57(101):720-7.

PMID:
21033217
14.

Follicular thyroid lesions, elements that affect both diagnosis and prognosis.

Zeiger MA, Dackiw AP.

J Surg Oncol. 2005 Mar 1;89(3):108-13. Review.

PMID:
15719377
15.

Beyond the suspicious thyroid fine needle aspirate. A review.

Segev DL, Clark DP, Zeiger MA, Umbricht C.

Acta Cytol. 2003 Sep-Oct;47(5):709-22. Review.

PMID:
14526667
16.

From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.

Albarel F, Conte-Devolx B, Oliver C.

Ann Endocrinol (Paris). 2012 Jun;73(3):155-64. doi: 10.1016/j.ando.2012.03.002. Epub 2012 Apr 13. Review.

PMID:
22503804
17.

Arginase 2 and nitric oxide synthase: Pathways associated with the pathogenesis of thyroid tumors.

Sousa MS, Latini FR, Monteiro HP, Cerutti JM.

Free Radic Biol Med. 2010 Sep 15;49(6):997-1007. doi: 10.1016/j.freeradbiomed.2010.06.006. Epub 2010 Jun 11.

PMID:
20542107
19.

Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma.

Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, Rumilla K, Lloyd RV.

Endocr Pathol. 2006 Fall;17(3):213-23.

PMID:
17308358
20.

The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.

Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.

Exp Oncol. 2006 Mar;28(1):70-4.

PMID:
16614712
Items per page

Supplemental Content

Write to the Help Desk